Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Antigenic Characterization of Human Monoclonal Antibodies for Therapeutic Use against H7N9 Avian Influenza Virus.

Autor: Chang P; The Pirbright Institute, Pirbright, Woking, United Kingdom., Lukosaityte D; The Pirbright Institute, Pirbright, Woking, United Kingdom., Sealy JE; The Pirbright Institute, Pirbright, Woking, United Kingdom., Rijal P; Center for Translational Immunology, Chinese Academy of Medical Science Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom., Sadeyen JR; The Pirbright Institute, Pirbright, Woking, United Kingdom., Bhat S; The Pirbright Institute, Pirbright, Woking, United Kingdom., Crossley S; The Pirbright Institute, Pirbright, Woking, United Kingdom., Daines R; The Pirbright Institute, Pirbright, Woking, United Kingdom., Huang KA; Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan., Townsend AR; Center for Translational Immunology, Chinese Academy of Medical Science Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom., Iqbal M; The Pirbright Institute, Pirbright, Woking, United Kingdom.

Publikováno v: Journal of virology [J Virol] 2023 Jan 31; Vol. 97 (1), pp. e0143122. Date of Electronic Publication: 2022 Dec 21.